← Back to Manufacturing

Pharmaceutical Preparation Manufacturing

Industry Overview

Stock Screener

Select filters to narrow down the 519 companies below

519 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

Lilly(Eli) & Co

LLY

Lilly(Eli) & Co

LLY
Market Cap $1.1T
Dividends 0.6%
P/E Ratio 39.3
Revenue $23B +47.7%
Net Income $7.1B +25.3%
Profit Margin +30.9%
View Stock

Johnson & Johnson

JNJ

Johnson & Johnson

JNJ
Market Cap $645.95B
Dividends 2.0%
P/E Ratio 31.0
Revenue $25.3B
Net Income $5.53B -0.1%
Profit Margin +21.9%
View Stock

Abbvie Inc

ABBV

Abbvie Inc

ABBV
Market Cap $451.38B
Dividends 2.7%
P/E Ratio 72.0
Revenue $17B +10.2%
Net Income $3.62B +285.8%
Profit Margin +21.3%
View Stock

Merck & Co Inc

MRK

Merck & Co Inc

MRK
Market Cap $366.18B
Dividends 2.3%
P/E Ratio 117.7
Revenue $16.6B +5.1%
Net Income -$1.34B -130.2%
Profit Margin -8.0%
View Stock

Abbott Laboratories

ABT

Abbott Laboratories

ABT
Market Cap $194.62B
Dividends 2.2%
P/E Ratio 36.2
Revenue $12.6B +13.0%
Net Income $928M -47.8%
Profit Margin +7.4%
View Stock

Pfizer Inc.

PFE

Pfizer Inc.

PFE
Market Cap $159.36B
Dividends 6.2%
P/E Ratio 36.9
Revenue $15B +2.6%
Net Income -$246M -108.5%
Profit Margin -1.6%
View Stock

Vertex Pharmaceuticals, Inc.

VRTX

Vertex Pharmaceuticals, Inc.

VRTX
Market Cap $137.48B
Dividends 0.0%
P/E Ratio 31.3
Revenue $3.33B +12.5%
Net Income $1.1B +6.5%
Profit Margin +33.0%
View Stock

Bristol-Myers Squibb Co.

BMY

Bristol-Myers Squibb Co.

BMY
Market Cap $136B
Dividends 3.8%
P/E Ratio 14.7
Revenue $13B +5.7%
Net Income $3.32B +153.2%
Profit Margin +25.6%
Employees 30.25K
View Stock

Regeneron Pharmaceuticals, Inc.

REGN

Regeneron Pharmaceuticals, Inc.

REGN
Market Cap $81.82B
Dividends 0.5%
P/E Ratio 19.0
Revenue $4.29B +16.7%
Net Income $1.3B -6.8%
Profit Margin +30.2%
View Stock

Teva- Pharmaceutical Industries Ltd. - ADR

TEVA

Teva- Pharmaceutical Industries Ltd. - ADR

TEVA
Market Cap $42.44B
Dividends 0.0%
P/E Ratio 57.8
Revenue $4.14B -0.8%
Net Income -$576M -304.3%
Profit Margin -13.9%
View Stock

Zoetis Inc - Ordinary Shares - Class A

ZTS

Zoetis Inc - Ordinary Shares - Class A

ZTS
Market Cap $32.42B
Dividends 2.7%
P/E Ratio 12.7
Revenue $2.47B +0.3%
Net Income $691M -3.8%
Profit Margin +28.0%
Employees 9.2K
View Stock

Alnylam Pharmaceuticals Inc

ALNY

Alnylam Pharmaceuticals Inc

ALNY
Market Cap $31.73B
Dividends 0.0%
P/E Ratio 38.9
Revenue $1.29B +66.9%
Net Income $164M -348.2%
Profit Margin +12.7%
View Stock

Horizon Therapeutics Plc

HZNP

Horizon Therapeutics Plc

HZNP
Market Cap $26.6B
Dividends 0.0%
P/E Ratio 51.0
Revenue $945M +7.8%
Net Income $127M +108.4%
Profit Margin +13.4%
View Stock

Insmed Inc

INSM

Insmed Inc

INSM
Market Cap $25.69B
Dividends 0.0%
P/E Ratio -28.8
Revenue $425M +296.1%
Net Income -$13.2M -95.9%
Profit Margin -3.1%
View Stock

United Therapeutics Corp

UTHR

United Therapeutics Corp

UTHR
Market Cap $21.88B
Dividends 0.0%
P/E Ratio 17.1
Revenue $783M -1.9%
Net Income $333M +7.6%
Profit Margin +42.5%
Employees 920
View Stock

BeiGene Ltd - ADR

BGNE

BeiGene Ltd - ADR

BGNE
Market Cap $20.21B
Dividends 0.0%
P/E Ratio 27.0
Revenue $1.71B +29.6%
Net Income $237M +151.3%
Profit Margin +13.9%
View Stock

Eisai Co Ltd - ADR

ESALY

Eisai Co Ltd - ADR

ESALY
Market Cap $17.64B
Dividends 3.3%
P/E Ratio 32.1
Revenue $188B
Net Income $9.12B
Profit Margin +4.9%
View Stock

Ascendis Pharma A/S - ADR

ASND

Ascendis Pharma A/S - ADR

ASND
Market Cap $15.4B
Dividends 0.0%
P/E Ratio 17.7
Revenue $345M +118.2%
Net Income $210M -641.5%
Profit Margin +61.0%
View Stock

Jazz Pharmaceuticals plc

JAZZ

Jazz Pharmaceuticals plc

JAZZ
Market Cap $15.36B
Dividends 0.0%
P/E Ratio 16.1
Revenue $1.21B +15.5%
Net Income $193M -126.8%
Profit Margin +16.0%
Employees 1.21K
View Stock

BridgeBio Pharma Inc

BBIO

BridgeBio Pharma Inc

BBIO
Market Cap $15B
Dividends 0.0%
P/E Ratio -21.4
Revenue $222M +101.2%
Net Income -$152M -16.3%
Profit Margin -68.4%
View Stock